| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |